ONWARD

30/03/2026

Veterans with spinal cord injuries face significant daily challenges. Innovative technologies have the potential to meaningfully impact their rehabilitation journey and everyday lives.

This month, Senator Jerry Moran, chairman of the US Senate Committee on Veterans’ Affairs, introduced the Veterans Spinal Trauma Access to New Devices (STAND) Act. The STAND Act has already been introduced in the US House of Representatives by Rep. Jack Bergman, Chairman of the House Committee on Veterans’ Affairs Mike Bost, Rep. Joe Neguse, and Rep. Josh Gottheimer. This bipartisan and bicameral legislation would ensure annual preventive health evaluations for Veterans living with SCI and other movement disorders and expand access to assistive technologies to better support their needs.

We fully support this important legislation and the expansion of access to innovative tools that support rehabilitation and autonomy, alongside leading organizations such as the Christopher & Dana Reeve Foundation, Paralyzed Veterans of America, Medical Device Manufacturers Association (M**A), and the ITEM (Independence through the Enhancement of Medicare and Medicaid) Coalition. The STAND Act is essential to ensuring Veterans receive the care they need and deserve, empowering them to thrive beyond their military service.

We are proud to deliver breakthrough therapies for living with and to contribute to their journey toward greater independence and improved quality of life.

Learn more about the STAND Act: https://www.veterans.senate.gov/2026/3/chairman-moran-introduces-legislation-to-improve-treatments-technology-for-veterans-with-spinal-cord-injuries

25/03/2026

“Some mornings I wake up feeling okay. Other days, my blood pressure is so low that I become lightheaded and dizzy, my ears ringing, struggling just to stay upright.”

Three years ago, a car accident left Cody Krebs with a spinal cord injury. Since then, he’s been learning how to navigate life while facing the challenges caused by blood pressure instability, where disruptions in the autonomic nervous system cause blood pressure to fluctuate between abnormally low and high levels.

▶️Watch the University of Calgary's video spotlighting Cody’s experience with the investigational ARC-IM Therapy: https://youtu.be/RLP-c13edWg?si=VlaYLv2i7i75Abtz

Our implantable neurostimulation technology designed to address symptomatic blood pressure instability after is now being evaluated as part of the Empower BP global pivotal trial. For more details about the study, please visit https://onwd.com/empower-bp/



ARC-IM® is investigational and not available for commercial use.

Cody Krebs shares his experience as a participant in a clinical trial led by researchers at the University of Calgary's Cu***ng School of Medicine. The study...

20/03/2026

We’re delighted to be attending the upcoming Spinal Injuries Ireland Empowerment Summit 2026 in Dublin, Ireland. This year’s conference, themed “Unlocking the Present for the Future,” brings together leading voices to spark new possibilities and empower the spinal cord injury community.

Join us for a deep dive into our groundbreaking ARC-EX® System, indicated to improve hand strength and sensation after , led by Miro Caban, PhD.

And don't miss inspiring trailblazer and ARC-EX Therapy trial participant Jessie Owen's talk, “The Long Middle: Life unfolding without a finish line.”

We hope to see you there!



ARC-EX Indication for Use (EU): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic (>1 year post-injury), non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

05/03/2026

“I’m gaining more range of motion in my fingers and in my right hand overall. I do a lot of woodworking, and I’ve been able to use my right hand more.”

Robert Ward, a native of Charlotte, North Carolina, sustained a spinal cord injury in an all-terrain vehicle accident. He shares his experience using the ARC-EX® System, the first and only US FDA-cleared technology indicated to improve hand strength and sensation after .

▶️ Listen to Robert’s positive outlook and how the ARC-EX has become a significant tool to support him on his journey to greater independence.



To find the nearest center offering ARC-EX near you, please check: https://www.onwd.com/center-locator/

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, nonprogressive neurological deficits resulting from an incomplete spinal cord injury (C2-C8 inclusive). The ARC-EX System is intended to be operated in medical centers by rehabilitation professionals and at home by patients and persons providing assistance to patients, as needed.

20/02/2026

On National Caregivers Day, we honor the incredible dedication, compassion, and strength of caregivers across the US and beyond.

Whether you are a family member or a friend supporting a loved one, or a healthcare professional providing essential care, your efforts make a difference.

Thank you for your commitment and for the immeasurable impact you make in people’s lives. Your resilience inspires us every day❤️

18/02/2026

Wonderful to read Jessie Owen’s story of independence, resilience, love, and motherhood in People Magazine.

As an ARC-EX® Therapy trial participant and an advocate for the spinal cord injury community, Jessie inspires us through her journey, sharing both the good and hard moments of living with .

Read the full story: https://people.com/after-crash-paralyzed-her-new-tech-gave-woman-confidence-date-again-now-married-mom-twins-11886646



ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, nonprogressive neurological deficits resulting from an incomplete spinal cord injury (C2-C8 inclusive). The ARC-EX System is intended to be operated in medical centers by rehabilitation professionals and at home by patients and persons providing assistance to patients, as needed.

Jessie Owen's life was upended when she became paralyzed in a car crash that also killed her parents. Years later, her life changed again thanks to new technology that helped restore some of her movement — and gave her back her zest for life.

17/02/2026

“Since using the ARC-EX® System, AJ has been able to start moving his left fingers, and his morning routine is a lot faster,” says Dr. Ashley Clark, founder of the Revive Neurorecovery Center. “Those changes have made him more independent and confident to do things on his own.”

“I am definitely able to move my hands more, and at home it is easier for me to pick things up with one hand more confidently,” adds Ashton “AJ” Walker, a Navy Veteran living with spinal cord injury.

▶️ Hear directly from Dr. Clark and Navy Veteran AJ Walker as they share their experiences since using the ARC-EX System, the first and only US FDA-cleared technology indicated to improve hand strength and sensation after .

To stay informed about our technologies, research studies, and the availability of therapies in your area, please complete the form linked in the comments.



ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, nonprogressive neurological deficits resulting from an incomplete spinal cord injury (C2-C8 inclusive). The ARC-EX System is intended to be operated in medical centers by rehabilitation professionals and at home by patients and persons providing assistance to patients, as needed.

04/02/2026

We are pleased to announce the enrollment of the first participant in Empower BP, a global pivotal study assessing the safety and effectiveness of the investigational ARC-IM® System in managing symptomatic blood pressure instability in people with chronic spinal cord injury. The study is expected to involve participants across approximately 20 leading neurorehabilitation and neurosurgical research centers in the US, Canada, France, Germany, Spain, and the UK. The first participant was enrolled at Craig Hospital in Denver, Colorado.

“The ARC-IM System is designed to address several unmet needs after , including symptomatic blood pressure instability. The clinical feasibility results published last year in Nature Medicine were outstanding, and we are hopeful Empower BP will provide the data needed to bring this important therapy to hospitals and clinics worldwide,” said Dave Marver, CEO of ONWARD Medical.

The initiation of Empower BP marks another significant milestone in our journey to restore critical autonomic functions impacted by spinal cord injury.

For more details about the study, please visit the link in the comments below.



ARC-IM® is an investigational device. It is limited by United States law to investigational use.

27/01/2026

"I felt dizzy all the time, I had no energy - I slept the entire day,” Julie Verlinden says.

In 2022, Julie was returning to Belgium from studying abroad when she was injured in a car accident and became paralyzed. Back home, she encountered an unexpected challenge: blood pressure instability.

After spinal cord injury, many people experience symptomatic blood pressure instability, where disruptions in the autonomic nervous system cause blood pressure to fluctuate between abnormally low and high levels. Blood pressure instability and persistent low blood pressure can threaten neurological recovery and negatively impact cardiovascular health and overall quality of life. In Julie’s case, it made sitting up, socializing, and even thinking difficult.

▶️ Julie is a clinical trial participant. In this video, she explains how our investigational ARC-IM® System, an implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation, helped her get her life back.

The ARC-IM System is currently being evaluated as part of Empower BP, a global pivotal study assessing the safety and efficacy of the implantable neurostimulation technology in addressing blood pressure instability following .

For more details about the study, please visit the link in the comments below.



ARC-IM® is investigational and not available for commercial use.

21/01/2026

“Paralysis affects your daily life. Since starting therapy, I’m definitely able to move my hands more. I’m able to hold a cup with one hand and drink from it, without worrying about dropping it.”

▶️ Afton “AJ” Walker is a US Navy veteran living with a spinal cord injury. In this video, he shares his recovery journey and the improvements he has experienced since using our ARC-EX® System, the first and only US FDA-cleared technology indicated to improve hand sensation and strength after .

AJ’s journey toward greater empowerment and independence is what inspires us every day to make a meaningful difference for the SCI community ❤️



To stay informed about our technologies, research studies, and the availability of therapies in your area, please complete the form linked in the comments.

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, nonprogressive neurological deficits resulting from an incomplete spinal cord injury (C2-C8 inclusive). The ARC-EX System is intended to be operated in medical centers by rehabilitation professionals and at home by patients and persons providing assistance to patients, as needed.

08/01/2026

“Most people don't realize how important blood pressure is until they lose control of it,” says Nuno Abreu.

In 2021, Nuno, a general surgeon based in Lisbon, Portugal, sustained a spinal cord injury in a bodyboarding accident. In addition to adjusting to life in a wheelchair, he faced another, invisible and debilitating challenge: blood pressure instability.

After spinal cord injury, many people experience symptomatic blood pressure instability, where disruptions in the autonomic nervous system cause blood pressure to fluctuate between abnormally low and high levels. Blood pressure instability and persistent low blood pressure can threaten neurological recovery and negatively impact cardiovascular health and overall quality of life.

▶️ Nuno is a clinical trial participant. Hear directly from him about how our investigational ARC-IM® System, an implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation, has helped him manage his blood pressure and feel better day to day.

The ARC-IM System is currently being evaluated as part of Empower BP, a global pivotal study assessing the safety and efficacy of the implantable neurostimulation technology in addressing blood pressure instability following .

For more details about the study, please visit the link in the comments below.



ARC-IM® is investigational and not available for commercial use.

05/01/2026

We are thrilled to announce the recent delivery of the first ARC-EX® Systems in Europe.

NeuroMove, located in Amsterdam, The Netherlands, is one of the first clinics to receive our groundbreaking spinal cord stimulation therapy, indicated to improve hand strength and sensation after spinal cord injury.

Thank you, Team NeuroMove, for your engagement during our training sessions, and for the essential work you’re doing every day to deliver care to those living with spinal cord injuries.

We look forward to continuing the launch of the ARC-EX System and to offering new recovery and care options for the community across Europe.



ARC-EX Indication for Use (EU): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic (>1 year post-injury), non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

Photos by Marcel Valkema